These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6536597)

  • 1. The use of in-vitro assays to study and to detect tumour promoters.
    Trosko JE; Jone C; Chang CC
    IARC Sci Publ; 1984; (56):239-52. PubMed ID: 6536597
    [No Abstract]   [Full Text] [Related]  

  • 2. Intercellular communication, cell differentiation and tumour promotion.
    Yamasaki H; Enomoto T; Martel N
    IARC Sci Publ; 1984; (56):217-38. PubMed ID: 6598800
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of intercellular communication by tumor promoters.
    Murray AW; Fitzgerald DJ; Guy GR
    Carcinog Compr Surv; 1982; 7():587-91. PubMed ID: 7066930
    [No Abstract]   [Full Text] [Related]  

  • 4. Short-term tests with biochemical end points relevant to the prediction of carcinogenic potential of drugs.
    Martin RA; de la Iglesia FA
    Drug Metab Rev; 1983; 14(3):513-55. PubMed ID: 6191938
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospects of short-term tests in primary cancer prevention.
    Khudoley VV; Pliss GB
    Neoplasma; 1984; 31(4):475-8. PubMed ID: 6472519
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor promotion--mechanisms and implication to risk estimation.
    Yamasaki H
    Acta Pharmacol Toxicol (Copenh); 1984; 55 Suppl 2():89-106. PubMed ID: 6385624
    [No Abstract]   [Full Text] [Related]  

  • 7. Initial cellular targets and eventual genomic changes in multistage carcinogenesis.
    Weinstein IB; Gattoni-Celli S; Kirschmeier P; Lambert M; Hsiao W; Backer J; Jeffrey A
    IARC Sci Publ; 1984; (56):277-97. PubMed ID: 6549538
    [No Abstract]   [Full Text] [Related]  

  • 8. Current concepts and controversies in chemical carcinogenesis.
    Weinstein IB
    J Supramol Struct Cell Biochem; 1981; 17(2):99-120. PubMed ID: 7033554
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenotypic and chromosomal alterations in cell cultures as indicators of tumor-promoting activity.
    Fusenig NE; Dzarlieva RT
    Carcinog Compr Surv; 1982; 7():201-16. PubMed ID: 7039829
    [No Abstract]   [Full Text] [Related]  

  • 10. Aquatic animal bioassays for carcinogenesis.
    Black JJ
    Transplant Proc; 1984 Apr; 16(2):406-11. PubMed ID: 6719546
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of tumor-promoting phorbol diesters on neoplastic progression of Syrian hamster embryo cells.
    O'Brien TG; Saladik D; Diamond L
    Cancer Res; 1982 Apr; 42(4):1233-8. PubMed ID: 7059999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2nd International symposium of the Society of Toxicologic Pathologists. Design of carcinogenicity studies: considerations in pathology interpretation. May 9-11, 1983, Arlington, Virginia.
    Toxicol Pathol; 1983; 11(1):28-95. PubMed ID: 6681393
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathological and biochemical aspects of tumour promotion.
    Hicks RM
    Carcinogenesis; 1983 Oct; 4(10):1209-14. PubMed ID: 6616751
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D; Mader R; Lee J; Hurta RA
    Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of intercellular communication by tumor-promoting phorbol esters.
    Fitzgerald DJ; Murray AW
    Cancer Res; 1980 Aug; 40(8 Pt 1):2935-7. PubMed ID: 7388843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol esters: structure, biological activity, and toxicity in animals.
    Goel G; Makkar HP; Francis G; Becker K
    Int J Toxicol; 2007; 26(4):279-88. PubMed ID: 17661218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and reversible inhibition of junctional communication by tumor promoters in a mouse cell line.
    Fitzgerald DJ; Knowles SE; Ballard FJ; Murray AW
    Cancer Res; 1983 Aug; 43(8):3614-8. PubMed ID: 6861133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-specific tumorigenesis in mouse skin induced by the carcinogen, 15,16-dihydro-11-methylcyclopenta[a]phenanthren-17-one, and its relation to DNA adduct formation and persistence.
    Abbott PJ
    Cancer Res; 1983 May; 43(5):2261-6. PubMed ID: 6831449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of oxidant formation in mouse skin in vivo by tumor-promoting phorbol esters.
    Marnett LJ; Ji C
    Cancer Res; 1994 Apr; 54(7 Suppl):1886s-1889s. PubMed ID: 8137305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrapolation of animal studies to the human situation.
    Zapp JA
    J Toxicol Environ Health; 1977 Jul; 2(6):1425-33. PubMed ID: 886632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.